Adia Nutrition Inc (PK) (ADIA) News

Nice Chart Reversal!

Great post as usual ty! 

Zero dilution 💥 

Good afternoon kemosabes! Bring on March madness 🔥 

A close of .085 would be Beautiful!

I believe once ADIA shows sales numbers, that's when this moves up Bigly!

Up green 36% so far today!

I could sure use an ADIA MedSpa right now.

Uplisting to OTCQB in Progress! Big Times Ahead! Patience is key!

I love when a plan comes together like this. ADIA Is an amazing one of a kind company!

All these paid promoters clamoring about how its such a great deal under .10, yet none are buying it here. Why is that?

Great update. Looking good. Anything under a dime is golden in my opinion.

$700 traded today.....

$ADIA is up 36% on news! https://www.newsfilecorp.com/release/242492/ADIA-Nutrition-Inc.-Ignites-2025-with-February-Breakthroughs-Riding-Adia-Meds-Profitable-January-Triumph

A PR summarizing all of the other PRs from January/Feb. The pump is unbelievable on this one. Gotta ask yourself why they are trying to pump this so hard with all of the promoters on it?

Chart forming a pennant formation. Next wave of buying will commence after bullish indicators are lit.

It's all setting up for March.

news, nice summray of recent activities: https://www.otcmarkets.com/stock/ADIA/news/ADIA-Nutrition-Inc-Ignites-2025-with-February-Breakthroughs-Riding-Adia-Meds-Profitable-January-Triumph?id=469228

Winter Park, Florida--(Newsfile Corp. - February 28, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a pioneer in healthcare innovation and regenerative medicine, concludes an extraordinary February with groundbreaking advancements in stem cell therapies, strategic partnerships, and a pivotal corporate milestone. These achievements, layered atop January's financial triumph at the Adia Med Winter Park Clinic, underscore ADIA Nutrition's unstoppable momentum toward revolutionizing healthcare, enhancing investor visibility, and delivering cutting-edge solutions nationwide.

February's transformative journey began on February 3, when Adia Med, the medical division of ADIA Nutrition, officially entered the $15.1 billion global stem cell market. Offering FDA-compliant treatments using 361 human cell, tissue, and cellular and tissue-based products (HCT/Ps), the clinic leverages high-quality umbilical cord stem cells to address conditions like inflammation, autoimmune disorders, and orthopedic issues-providing a U.S.-based alternative to international hubs like Panama and Switzerland. On February 5, the company took a significant step toward uplisting from OTC Pink to the OTCQB Venture Market by appointing a PCAOB-registered accounting firm for a third-party audit, boosting transparency and laying groundwork for a future Nasdaq Small Cap listing.

The month gained further traction mid-February. On February 11, ADIA Nutrition tackled historical share issuance concerns, pledging to retire over 25 million undocumented shares-cutting outstanding shares by approximately 15 percent-and reinforcing its commitment to shareholder integrity. On February 13, Adia Med advanced its registration with Florida's Agency for Health Care Administration (AHCA), aiming to secure private insurance coverage for therapies like Autologous Hematopoietic Stem Cell Transplantation (aHSCT) and stem cell injectables, enhancing affordability. On February 18, a partnership with a premier FDA-approved laboratory ensured a steady supply of top-tier umbilical cord stem cell and exosome products, featuring 100 million viable cells and 3 trillion exosomes per dose, cementing Adia Med's leadership in regenerative medicine quality.

February's pinnacle arrived with three standout milestones that underscored ADIA Nutrition's rapid progress in regenerative medicine and corporate growth. These achievements highlighted the company's innovation, scalability, and commitment to enhancing investor confidence, marking a transformative close to the month.

February's Standout Milestones:

February 20: ADIA Nutrition launched Adia Labs LLC, unveiling Adia Vita-a branded stem cell product containing 100 million viable cells and 3 trillion exosomes per dose for clinical research and therapeutic use, targeting a market of over 1 million doctors and clinics.

February 24: Adia Med announced a nationwide expansion plan, partnering with elite Medical Spas to create satellite locations in health-conscious regions, offering a scalable, low-risk model to boost revenue and service reach.

February 26: ADIA Nutrition achieved a critical corporate victory as OTC Markets removed its shell risk designation, a key requirement for OTCQB uplisting, expedited through close collaboration with OTC Markets, highlighting the company's operational integrity and accelerating its path to greater liquidity and investor trust.

These February triumphs build on January's success, when the Adia Med Winter Park Clinic exceeded financial expectations in its first operational month, covering all opening expenses with surplus revenue. Treating conditions like Multiple Sclerosis (MS), hip issues, torn tendons, and joint pain with umbilical cord stem cells (UCB-SC), the clinic demonstrated the wide-reaching impact of its regenerative therapies. "January's financial strength gave us a solid base, and February's leaps-including the shell risk removal and Adia Labs' progress-propel us forward," said Larry Powalisz, CEO of ADIA Nutrition. "We're thrilled to thank OTC Markets for their swift support in clearing this hurdle, allowing me to share exciting updates with our investors that I couldn't before. This is just the start."

The OTCQB uplisting process, now in clear sight with the shell risk designation lifted, will elevate ADIA Nutrition's visibility to a broader investor audience. The Med Spa partnerships will efficiently scale operations, while the lab collaboration ensures product excellence. The share retirement effort further solidifies corporate governance, amplifying investor confidence, as ADIA Nutrition strengthens its position as a leader in regenerative medicine innovation.

Looking forward, ADIA Nutrition plans to replicate the Winter Park Clinic model in new markets, expand satellite locations, and complete its OTCQB uplisting with Nasdaq aspirations on the horizon. These efforts promise enhanced shareholder value and cutting-edge care for diverse communities. "From January's financial win to February's strategic breakthroughs, we're redefining healthcare possibilities," Powalisz added. "We're committed to innovation, accessibility, and sustainable growth for our stakeholders."

For questions, inquiries, or further information, contact Larry Powalisz at ceo @101Dahlias-0850.

About ADIA Nutrition Inc.:
ADIA Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, it operates two key divisions: a supplement division offering premium, organic supplements, and a medical division establishing clinics specializing in leading-edge stem cell therapies, including Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these efforts, ADIA Nutrition empowers individuals to live their best lives by addressing nutritional needs and groundbreaking medical treatments.

Website: www.adianutrition.com

Website: www.adia-med.com

Website: www.adialabs.com

Website: www.biolete.com

Website: www.cementfactory.co

Twitter (X): @ADIA_Nutrition

Keeping a strong watch on $ADIA. This is primed for a breakout.

$ADIA's recent achievements >>
Shell Risk Designation Removed: The company successfully eliminated its shell risk designation from OTC Markets, advancing toward an uplisting to the OTCQB Venture Market.
Expansion of Adia Med Clinics: Adia Nutrition is expanding its Adia Med satellite locations nationwide through partnerships with premier medical spas. This initiative aims to make regenerative medicine treatments more accessible across the United States.
Launch of Adia Labs LLC: The company has introduced Adia Labs LLC, focusing on regenerative medicine. They've begun sales of branded stem cell products, including AdiaVita and the upcoming AdiaLink, which offer advanced stem cell therapies.

This is the biggest promoter/pumper circle jerk Ive seen in a while lol

Yup, and the CEO will answer any and all your questions quite quickly. Just email call or text

This is one of the most transparent companies on the OTC that I've seen in a long time!

$ADIA

The chart is churning nicely this week ... Setting up for March.

Buy the dips and sell the rips.

It's coming

Removal of Shell Risk brings Adia one step closer to filing OTCQB forms.
"The auditors are and have been working with Adia's CFO and Adia's Accountants to expedit the audit. Once the auditors are finished we can then Submit for OTCQB."

"Lot's more news to come!!!"

Notice this one interesting line from this particular Med Spa franchise in the making...

"Proprietary biologic
compositions of stem cells, amniotic fluid, exosomes, and other
growth factors are sometimes used with BES to facilitate healing."

Here's the link to how Lionheart Health is taking the franchise path towards Med Spas. I have no idea if that company has any affiliation whatsoever with ADIA but it was curious to me as to how they incorporated stem cells and exosomes into their summary in their Med Spa business. The link of their full summary about their Med Spa approach is linked below.

Lionheart Health Executive Summary 2024

Didn't realize how big the Med Spa industry has gotten. I was thinking the CEO had a small chain of spas in mind.

However, I Googled how many Med Spas in the U.S. and a top result showed over 8,800 back in 2022, with an average revenue around $1.9 million annually.

Maybe ADIA can supply a massive quantity of stem cells around the country!

Thats great !!!!!!! ADIA $$$$$$

ADIA doing things the right way. Going bigtime!

The company is committed to transparency which they have proved through a consistent stream of news releases and CEO updates.

$ADIA

Stay tuned for further updates as Adia Nutrition continues to push boundaries in the industry.

ADIA "promising a wealth of exciting developments on the horizon."

The company has been working closely with OTC Markets to fulfill all uplisting criteria, including a comprehensive third-party audit, and thanks OTC Markets for their partnership in expediting the shell risk removal process. This rapid progress highlights Adia Nutrition's proactive approach and sets the stage for an imminent uplisting.

Adia Removal of Shell Risk Designation by OTC Markets,

Advancing Toward OTCQB Uplisting

agreed

Lets get over 10 chart is setting up

Adia Nutrition Announces Successful Removal of Shell Risk Designation by OTC Markets, Advancing Toward OTCQB Uplisting

Yes sir, one step at a time!

Up 14% on the day so far!

$ADIA

Those who think .17 was a one day wonder ... Tink again ... akkumulation inprogeess

Healthy trading here ... Churn churn churn ... Until it's splash time.

Holding.

Movin along!

Getting insurance approval is key. CEO has private insurers already willing to pay once the state of Florida gets us our administrative approval. Who know how long that takes. They probably come inspect the building and might suggest those units that hang on the wall that dispense anti-bacterial foam as I've seen in other medical facilities. Still, there should be nothing that the company can't easily rectify once they get the inspection. But having the private insurers on board already is so unbelievably huge!

For all those Med Spa locations that the CEO wants to sign up, it's likely that one deterrent for them in the past for not doing stem cell therapy is that insurance didn't cover basic stem cell procedures. Kinda feels like our CEO is spear-heading the effort to make insurance a standard practice, which could bring all of those MedSpa companies a lot of extra business.

While we wait, sure wish you guys would at least take a glance at my other MedSpa connected play that has a sub $300,000 market cap. Over here, the CEO was hoping we would get that state approval within 30 days and that was almost 2 weeks ago if I recall.

No way! Great news. Another step closer. Now we just need that administrative approval from the state of Florida to validate their clinic and then those customers waiting in line with pre-approved insurance should start firing up the revenue engine in a big way.

Bring on March Madness Bill buddy! 

ADIA's coiling like a viper>>>$$$$$$$$$$$

Another excellent step Aya boom! 

Let's goooooooooo bb 🔥 

Who is performing the audit for them?